{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T20:44:06Z","timestamp":1782765846096,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1007\/bf02988205","type":"journal-article","created":{"date-parts":[[2008,11,13]],"date-time":"2008-11-13T14:37:19Z","timestamp":1226587039000},"source":"Crossref","is-referenced-by-count":28,"title":["Palliative analgesic effect of Re-186 HEDP in various cancer patients with bone metastases"],"prefix":"10.1007","volume":"14","author":[{"given":"N. \u00d6.","family":"K\u00fc\u00e7\u00fck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"\u0130bi\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Aras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Baltaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"\u00d6zalp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Bed\u00fck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"\u00c7anakci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Soylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF02988205_CR1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1200\/JCO.1991.9.3.509","volume":"9","author":"OS Nielson","year":"1991","unstructured":"Nielson OS, Munro AJ, Tannock IF. Bone metastases; pathophysiology and management policy.J Clin Oncol 9: 509\u2013524, 1991.","journal-title":"J Clin Oncol"},{"key":"BF02988205_CR2","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/0277-5379(91)90254-B","volume":"27","author":"PJ Hoskin","year":"1991","unstructured":"Hoskin PJ. Palliation of bone metastases.Eur J Cancer 27: 950\u2013951, 1991.","journal-title":"Eur J Cancer"},{"key":"BF02988205_CR3","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0022-5347(17)40897-4","volume":"141","author":"DA Kuban","year":"1989","unstructured":"Kuban DA, Delbridge T, el-Mahdi AM, Schellhammer PF. Half-body irradiation for treatment of widely metastatic adenocarcinoma of the prostate.J Urol 141: 572\u2013574, 1989.","journal-title":"J Urol"},{"key":"BF02988205_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/0167-8140(89)90053-4","volume":"14","author":"G Arcangeli","year":"1989","unstructured":"Arcangeli G, Micheli A, Arcangeli G, Giannarelli D, La Pasta O, Tolis A, et al. The responsiveness of bone metastases to radiotherapy: the effect of site, histology and radiation dose on pain relief.Radiother Oncol 14: 95\u2013101, 1989.","journal-title":"Radiother Oncol"},{"issue":"suppl","key":"BF02988205_CR5","first-page":"31","volume":"5","author":"A Lipton","year":"1994","unstructured":"Lipton A, Glover D, Harvey H, Grabelsky S, Zelenakas K, Macerata R, et al. Pamidronate in the treatment of bone metastases: results of 2 dose ranging trials in patients with breast or prostate cancer.Ann Oncol 5 (suppl): S 31\u201335, 1994.","journal-title":"Ann Oncol"},{"key":"BF02988205_CR6","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/978-1-4615-3398-6_30","volume":"324","author":"I Takahashi","year":"1992","unstructured":"Takahashi I, Niibe H, Mitsuhashi N, Ikeda H, Imai K, Yamanaka H. Paliative radiotherapy of bone metastasis.Adv Exp Med Biol 324: 277\u2013282, 1992.","journal-title":"Adv Exp Med Biol"},{"key":"BF02988205_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/BF02261248","volume":"20","author":"WJ Lewington","year":"1993","unstructured":"Lewington WJ. Targeted radionuclide therapy for bone metastases.Eur J Nucl Med 20: 66\u201374, 1993.","journal-title":"Eur J Nucl Med"},{"key":"BF02988205_CR8","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S0749-2081(85)80042-5","volume":"1","author":"N Coyle","year":"1985","unstructured":"Coyle N, Foley K. Pain in patients with cancer: profile of patients and common pain syndromes.Sem Oncol Nurs 1: 93\u201399, 1985.","journal-title":"Sem Oncol Nurs"},{"issue":"1","key":"BF02988205_CR9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S0001-2998(05)80152-7","volume":"22","author":"F Hosain","year":"1996","unstructured":"Hosain F, Spencer RP. Radiopharmaceuticals for palliation of metastatic osseous lesions, biologic and physical background.Sem Nucl Med 22 (1): 11\u201316, 1996.","journal-title":"Sem Nucl Med"},{"key":"BF02988205_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0936-6555(05)80172-4","volume":"2","author":"NG Burnet","year":"1990","unstructured":"Burnet NG, Williams G, Howard N. Phosphorus-32 for intractable bony pain from carcinoma of the prostate.Clin Oncol 2: 220\u2013223, 1990.","journal-title":"Clin Oncol"},{"key":"BF02988205_CR11","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1148\/98.2.343","volume":"98","author":"EC Tong","year":"1971","unstructured":"Tong EC. Parathormone and P-32 therapy in prostatic cancer with bone metastases.Radiology 98: 343\u2013351, 1971.","journal-title":"Radiology"},{"key":"BF02988205_CR12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0022-5347(17)60353-7","volume":"109","author":"ECK Tong","year":"1973","unstructured":"Tong ECK, Finkelstein P. The treatment of prostatic bony metastases with parathormone and radioactive phosphorus.J Urol 109: 71\u201375, 1973.","journal-title":"J Urol"},{"key":"BF02988205_CR13","first-page":"10","volume":"20","author":"EB Silberstein","year":"1973","unstructured":"Silberstein EB. The treatment of painful osseous metastases with phosphorus 32 labeled phosphates.Semin Oncol 20: 10\u201321, 1973.","journal-title":"Semin Oncol"},{"key":"BF02988205_CR14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF00254749","volume":"12","author":"GM Blake","year":"1986","unstructured":"Blake GM, Zivanovic MA, McEwan AJ, Ackery DM. Sr-89 therapy: strontium kinetics in disseminated carcinoma of the prostate.Eur J Nucl Med 12: 447\u2013454, 1986.","journal-title":"Eur J Nucl Med"},{"key":"BF02988205_CR15","first-page":"41","volume":"3","author":"GM Blake","year":"1987","unstructured":"Blake GM, Zivanovic MA, McEwan AJ, Batty VB, Ackery DM. Sr-89 radionuclide therapy: dosimetry and hematological toxicity in two patients with metastasising prostatic carcinoma.Eur J Nucl Med 3: 41\u201346, 1987.","journal-title":"Eur J Nucl Med"},{"key":"BF02988205_CR16","first-page":"345","volume":"26","author":"EB Silberstein","year":"1985","unstructured":"Silberstein EB, Williams C. Strontium-89 therapy for the pain of osseous metastases.J Nucl Med 26: 345\u2013348, 1985.","journal-title":"J Nucl Med"},{"key":"BF02988205_CR17","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1200\/JCO.1989.7.12.1926","volume":"7","author":"JH Turner","year":"1989","unstructured":"Turner JH, Claringbold PG, Hetherington EL, Sorby P, Martindale AA. A phase 1 study of samarium-153 ethylene diamine tetramethylene phosphonate therapy for disseminated skeletal metastases.J Clin Oncol 7: 1926\u20131931, 1989.","journal-title":"J Clin Oncol"},{"key":"BF02988205_CR18","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/0277-5379(91)90297-Q","volume":"27","author":"JH Turner","year":"1991","unstructured":"Turner JH, Claringbold PG. A phase II study of treatment of painful multifocal skeletal metastases with single and repeated dose Samarium-153 ethylenediamine tetramethylene phosphonate.Eur J Cancer 27: 1084\u20131086, 1991.","journal-title":"Eur J Cancer"},{"key":"BF02988205_CR19","first-page":"784","volume":"15","author":"JH Turner","year":"1989","unstructured":"Turner JH, Martindale AA, Sorby P, Hetherington EL, Fleay PH, Hoffman RE, et al. Samarium 153-EDTMP therapy of disseminated skeletal metastasis.Eur J Nuc Med 15: 784\u2013795, 1989.","journal-title":"Eur J Nuc Med"},{"key":"BF02988205_CR20","first-page":"1839","volume":"34","author":"C Collins","year":"1993","unstructured":"Collins C, Eary JF, Donaldson G, Vernon C, Bush NE, Petersdorf S, et al. Samarium-153 EDTMP in bone metastases of hormone refractory prostate carcinoma: a phase I\/II trial.J Nucl Med 34: 1839\u20131844, 1993.","journal-title":"J Nucl Med"},{"key":"BF02988205_CR21","first-page":"1451","volume":"33","author":"H Farhanghi","year":"1992","unstructured":"Farhanghi H, Holmes RA, Volkert WA, Logan W, Singh A. Samarium-153 EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer.J Nucl Med 33: 1451\u20131458, 1992.","journal-title":"J Nucl Med"},{"key":"BF02988205_CR22","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1148\/radiology.186.1.7677974","volume":"186","author":"HL Atkins","year":"1993","unstructured":"Atkins HL, Mausner LF, Srivastava SC, Meinken GE, Straub RF, Cabahug CJ, et al. Biodistribution of Sn 117m (4+) DTPA for palliative therapy of painful osseous metastases.Radiology 186: 279\u2013283, 1993.","journal-title":"Radiology"},{"key":"BF02988205_CR23","unstructured":"Atkins HL, Mausner LF, Meinken GE, Srivastava SC, Klopper JF, Cabahug CJ, et al. Palliation of bone pain with Sn 117m (4+) DTPA.J Nucl Med 35: 37P, 1994."},{"key":"BF02988205_CR24","first-page":"1255","volume":"27","author":"M Eisenhut","year":"1986","unstructured":"Eisenhut M, Berberich R, Kimming B, Oberhausen E. Iodine-131 labeled diphosphonates for palliative treatment of bone metastasis: II. Preliminary clinical results with iodine-131 BDP3.J Nucl Med 27: 1255\u20131261, 1986.","journal-title":"J Nucl Med"},{"key":"BF02988205_CR25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1148\/radiology.166.2.3122267","volume":"166","author":"HR Maxon","year":"1988","unstructured":"Maxon HR, Deutsch EA, Thomas SR, Libson K, Lukes SJ, Williams CC, et al. Re-186 (Sn) HEDP for treatment of multiple metastatic foci in bone; human biodistribution and dosimetric studies.Radiology 166: 501\u2013507, 1988.","journal-title":"Radiology"},{"key":"BF02988205_CR26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1148\/radiology.176.1.1693784","volume":"176","author":"HR Maxon","year":"1990","unstructured":"Maxon HR 3d, Schroder LE, Thomas SR, Hertzberg US, Deutsch EA, Scher HI, et al. Re-186 (Sn) HEDP for treatment of painful osseous metastases: initial clinical experience with 20 patients with hormone-resistant prostate cancer.Radiology 176: 155\u2013159, 1990.","journal-title":"Radiology"},{"key":"BF02988205_CR27","first-page":"1877","volume":"32","author":"HR Maxon","year":"1991","unstructured":"Maxon HR 3d, Schroder LE, Hertzberg VS, Thomas SR, Englaro EE, Samaratunga R, et al. Rhenium-186 (Sn) HEDP for treatment of painful osseous metastases: results of a double-blind crossover comparison with placebo.J Nucl Med 32: 1877\u20131881, 1991.","journal-title":"J Nucl Med"},{"issue":"1","key":"BF02988205_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0001-2998(05)80155-2","volume":"22","author":"HR Maxon","year":"1992","unstructured":"Maxon HR 3d, Thomas SR, Hetrzberg VS, Schroder LE, Englaro EE, Samaratunga R, et al. Rhenium-186 hydroxyethylidene diphosphonate for the treatment of painful osseous metastases.Semin Nucl Med 22 (1): 33\u201340, 1992.","journal-title":"Semin Nucl Med"},{"key":"BF02988205_CR29","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1212\/WNL.40.6.997","volume":"40","author":"SR Gupta","year":"1990","unstructured":"Gupta SR, Zdonczyk DE, Rubino FA. Cranial neuropathy in systemic malignancy in a VA population.Neurology 40: 997\u2013999, 1990.","journal-title":"Neurology"},{"key":"BF02988205_CR30","first-page":"646","volume":"33","author":"JM de Klerk","year":"1992","unstructured":"de Klerk JM, van Dijk A, van het Schip AD, Zonneberg BA, van Rijk PP. Pharmocokinetics of rhenium-186 after administration of rhenium-186 to patients with bone metastases.J Nucl Med 33: 646\u2013651, 1992.","journal-title":"J Nucl Med"},{"key":"BF02988205_CR31","first-page":"1423","volume":"35","author":"JM de Klerk","year":"1994","unstructured":"de Klerk JM, van het Schip AD, Zonnenberg BA, van Dijk A, Stokkel MP, Han SH, et al. Evaluation of thrombocytopenia in patients treated with rhenium-186 HEDP: guidelines for individual dosage recommendations.J Nucl Med 35: 1423\u20131428, 1994.","journal-title":"J Nucl Med"},{"key":"BF02988205_CR32","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/BF00181067","volume":"35","author":"JM de Klerk","year":"1994","unstructured":"de Klerk JM, Zonnenberg BA, van het Schip AD, van Dijk A, Han SH, Quirijnen JM, et al. Dose escalation study of rhenium-186 hydroxyethylidene diphosphonate in patients with metastatic prostate cancer.Eur J Nucl Med 35: 1114\u20131120, 1994.","journal-title":"Eur J Nucl Med"},{"key":"BF02988205_CR33","first-page":"876","volume":"20","author":"JM de Klerk","year":"1993","unstructured":"de Klerk JM, van het Schip AD, Zonnenberg BA, van Dijk A, van Rijk PP. Farmacokinetics of Re 186 HEDP; comparison of two formulations in patients with bone metastases.Eur J Nucl Med 20: 876, 1993.","journal-title":"Eur J Nucl Med"},{"key":"BF02988205_CR34","first-page":"732","volume":"30","author":"A Roodt","year":"1989","unstructured":"Roodt A, Libson K, Cutler C, Deutach E, Thoman SR, Maxon HR. Studies on the mechanism of action of 186-Re (Sn)-HEDP, a new agent for the treatment of painful skeletal metastases.J Nucl Med 30: 732, 1989.","journal-title":"J Nucl Med"},{"key":"BF02988205_CR35","first-page":"1511","volume":"37","author":"JM Quirinjnen","year":"1996","unstructured":"Quirinjnen JM, Han SH, Zonnenberg BA, de Klerk JM, van het Schip AD, et al. Efficacy of rhenium-186-etidronate in prostate cancer patients with metastatic bone pain.J Nucl Med 37: 1511\u20131515, 1996.","journal-title":"J Nucl Med"},{"key":"BF02988205_CR36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/clinchem\/39.1.131","volume":"39","author":"L Moro","year":"1993","unstructured":"Moro L, Gazzarrini C, Crivellari D, Galligioni E, Talamini R, de Bernard B. Biochemical markers for detecting bone metastases in patients with breast cancer.Clin Chem 39: 131\u2013134, 1993.","journal-title":"Clin Chem"},{"key":"BF02988205_CR37","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0022-5347(17)38972-3","volume":"142","author":"MLA Hudson","year":"1989","unstructured":"Hudson MLA. Clinical use of prostate specific antigen in patients with prostate cancer.J Urol 142: 1011\u20131017, 1989.","journal-title":"J Urol"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02988205\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988205","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02988205.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T21:44:48Z","timestamp":1652737488000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02988205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["BF02988205"],"URL":"https:\/\/doi.org\/10.1007\/bf02988205","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]},"article-number":"239"}}